Amneal Pharmaceuticals, Inc. AMRX
21.12 USD -0.27 (-1.26%)
Regular-session close
21.78 +0.66 +3.15%
After hours · Nov 20, 6:11 PM ET
21.07 Day range 21.70
11.52 52-week range 21.88
- YTD
- +67.62%
- 1 year
- +83.33%
AMRX revenue history
Revenue is income from the company’s ordinary business activities.
3,018,760,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 3,018,760,000 | 224,803,000 | 8.05% |
| FY 2024 | 2024-12-31 | 2,793,957,000 | 400,350,000 | 16.73% |
| FY 2023 | 2023-12-31 | 2,393,607,000 | 181,303,000 | 8.20% |
| FY 2022 | 2022-12-31 | 2,212,304,000 | 118,635,000 | 5.67% |
| FY 2021 | 2021-12-31 | 2,093,669,000 | 101,146,000 | 5.08% |
| FY 2020 | 2020-12-31 | 1,992,523,000 | 366,150,000 | 22.51% |
| FY 2019 | 2019-12-31 | 1,626,373,000 | -36,618,000 | -2.20% |
| FY 2018 | 2018-12-31 | 1,662,991,000 | 629,337,000 | 60.88% |
| FY 2017 | 2017-12-31 | 1,033,654,000 | 15,429,000 | 1.52% |
| FY 2016 | 2016-12-31 | 1,018,225,000 | 151,945,000 | 17.54% |
| FY 2015 | 2015-12-31 | 866,280,000 | 80,657,000 | 10.27% |
| FY 2014 | 2014-12-31 | 785,623,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-11T07:00:37.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
